Skip to contentI
INSMED Inc
I
INSMINSMED Inc Q2 2020 · 10-Q
Revenue$42.50M$42.50M+41.8% vs Q2 2019 Net Income-$61.85M-$61.85MN/M vs Q2 2019 EPS Diluted-$0.64-$0.64N/M vs Q2 2019 Gross Profit$32,545,000+29.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
INSMED Inc · CIK 1104506 · Engraved from SEC EDGAR
Operating Cash Flowderived-$35,953,000N/M Free Cash Flowderived-$37,834,000N/M Margins · derivedGross margin76.6%−7.0 pt vs Q2 2019
Operating margin-127.3%+80.1 pt vs Q2 2019
Net margin-145.6%+76.4 pt vs Q2 2019
ended Jun 30, 2020 · filed Aug 6, 2020 · 37 d after period end